scoparone has been researched along with Prostatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, WJ; Harris, RA; Kim, HJ; Kim, JK; Kim, JY; Lee, IK; Lee, JT; Park, KG | 1 |
1 other study(ies) available for scoparone and Prostatic Neoplasms
Article | Year |
---|---|
Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity.
Topics: Animals; Antineoplastic Agents; Artemisia; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Coumarins; Cyclin D1; G1 Phase; HCT116 Cells; HeLa Cells; Hep G2 Cells; HT29 Cells; Humans; Inhibitor of Apoptosis Proteins; Interleukin-6; Janus Kinase 2; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Survivin; Transcription, Genetic | 2013 |